The US Food and Drug Administration (FDA) announced yesterday that it will not appeal a court order directing the FDA to make emergency contraception available over-the-counter to women as young as 17. Edward Korman, a New York District Court Judge, ruled in March that the FDA must reconsider its 2006 ruling that allowed emergency contraception, also known as Plan B, to be sold without a prescription to women 18 and older (see PDF).
In a statement, the FDA stated "In accordance with the court's order, and consistent with the scientific findings made in 2005 by the Center for Drug Evaluation and Research, FDA notified the manufacturer of Plan B informing the company that it may….market Plan B without a prescription to women 17 years of age and older."
Emergency contraception is effective up to five days (120 hours) after unprotected sex, birth control failure, or rape, but it is most effective (95 percent) if taken within 24 hours. Because of the time-sensitive nature of EC, over-the-counter access is crucial to its effective use.
Media Resources: Feminist Daily Newswire 3/24/09; Food and Drug Administration Press Release 4/22/09
10/12/2015 Report Finds Texas' HB2 Increases Abortion Wait Times - A new report released by the University of Texas at Austin, Texas Policy Evaluation Project found patients seeking abortions in Texas have experienced an increase in wait times since the passage of HB2, the 2013 Texas omnibus anti-abortion bill that attempts to cut off abortion access by requiring abortion providers in the state to fulfill medically unnecessary ambulatory surgical center requirements and secure hospital admitting privileges.
More than half of 42 clinics providing abortion in Texas have been forced to shut their doors since HB2 passed two years ago, leading Texas women to wait up to 20 days for a first consult at one of the surviving 18 reproductive health clinics operating in the state, the second most populous in the nation. . . .
10/9/2015 Federal Judge Orders Anti-Abortion Group to Cede Footage to NAF - On Tuesday, a federal judge ruled that anti-abortion group Center for Medical Progress (CMP) and its leader David Daleidan must turn over all previously unreleased "sting" videos and outtakes of National Abortion Federation (NAF) meetings the group obtained surreptitiously as part of a smear campaign against the abortion provider.
U.S. . . .
10/9/2015 Women Scientists Receive Less Funding Than Their Male Peers, Study Finds - According to a new study published by the Journal of the American Medical Association, male scientists receive twice as much financial support to kickstart their careers in science and medicine as their female counterparts, an early career inequity that could limit professional opportunities for women scientists throughout their working lives.
Conducted by Health Resources in Action (HRiA), analysts studied 219 biomedical researchers who had applied for early-career grant funding at 55 New England hospitals, universities and research facilities between 2012 and 2014. . . .